Time to Maximum Plasma Concentration of Motesanib (Tmax) for Cycle 1 Cycle 1, Day 3 at predose, 15 and 30 minutes, and at 1, 2, 4, 6, 10 (QD cohorts only), and 24 hours post-dose. [clinicaltrials_resource:965b2b835469a28b17439401d0260160]
The time after dosing that the maximal plasma concentration of motesanib was observed in Cycle 1. For the 75 mg BID cohorts, Tmax is reported for the first daily dose.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Time to Maximum Plasma Concentration of Motesanib (Tmax) for Cycle 1 Cycle 1, Day 3 at predose, 15 and 30 minutes, and at 1, 2, 4, 6, 10 (QD cohorts only), and 24 hours post-dose. [clinicaltrials_resource:965b2b835469a28b17439401d0260160]
The time after dosing that the maximal plasma concentration of motesanib was observed in Cycle 1. For the 75 mg BID cohorts, Tmax is reported for the first daily dose.
Bio2RDF identifier
965b2b835469a28b17439401d0260160
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:965b2b835469a28b17439401d0260160
measure [clinicaltrials_vocabulary:measure]
Time to Maximum Plasma Concentration of Motesanib (Tmax) for Cycle 1
time frame [clinicaltrials_vocabulary:time-frame]
Cycle 1, Day 3 at predose, 15 ...... only), and 24 hours post-dose.
description
The time after dosing that the ...... rted for the first daily dose.
identifier
clinicaltrials_resource:965b2b835469a28b17439401d0260160
title
Time to Maximum Plasma Concent ...... only), and 24 hours post-dose.
@en
type
label
Time to Maximum Plasma Concent ...... b2b835469a28b17439401d0260160]
@en